首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >In vitro activity of tigecycline against methicillin-resistant Staphylococcus aureus, including livestock-associated strains.
【24h】

In vitro activity of tigecycline against methicillin-resistant Staphylococcus aureus, including livestock-associated strains.

机译:替加环素对耐甲氧西林的金黄色葡萄球菌(包括与牲畜有关的菌株)的体外活性。

获取原文
获取原文并翻译 | 示例
           

摘要

The in vitro activity of tigecycline was determined using a well-defined collection of methicillin-resistant Staphylococcus aureus (MRSA) isolates (n = 202), including 33 livestock-associated strains. Susceptibility testing was performed using the Etest system. Among the 202 MRSA strains, three (1.5%) had a minimum inhibitory concentration (MIC) value for tigecycline greater than 0.5 mg/l, which are considered to be resistant. When these strains were tested using Iso-Sensitest medium, the MICs were substantially lower and no resistance was found. This discrepancy warrants further investigations into the preferred test conditions for tigecycline. In conclusion, tigecycline showed good activity against MRSA strains in vitro.
机译:使用明确定义的耐甲氧西林金黄色葡萄球菌(MRSA)分离株(n = 202),包括33个与牲畜相关的菌株,对替加环素的体外活性进行了测定。敏感性测试使用Etest系统进行。在202株MRSA菌株中,三株(1.5%)的替加环素最低抑菌浓度(MIC)值大于0.5 mg / l,被认为具有耐药性。当使用Iso-Sensitest培养基测试这些菌株时,MIC显着降低,没有发现抗药性。这种差异值得进一步研究替加环素的首选测试条件。总之,替加环素在体外对MRSA菌株表现出良好的活性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号